Pfizer
Statistics report about the pharmaceutical company Pfizer
This report presents key facts and figures about U.S.-based pharmaceutical company Pfizer. Pfizer Inc. is the world's largest pharma company based on pharmaceutical revenue. This report shows the company's role in global pharma, revenues, major products, expenses, etc.
Pages
32 Pages
Format
PPTX
,
PDF
Language
English
Released
2026
Access
Download from this page
Comprehensive data insights
Includes all relevant statistics
Compiled by our industry experts
Table of contents
Global positioning
5
Premium
Statistic
Pharmaceutical market size worldwide 2001-2029
Premium
Statistic
Major 50 pharmaceutical companies - Rx sales and R&D spending 2024
Premium
Statistic
World's most valuable pharmaceutical brands 2025 by brand value
Premium
Statistic
Largest M&A pharmaceutical deals ever as of 2024
Basic
Statistic
Leading global biopharma drugs by lifetime revenue 1997-2024
Key company data
5
Premium
Statistic
Pfizer revenue 2006-2025
Premium
Statistic
Pfizer net income 2006-2025
Basic
Statistic
Earnings per Pfizer share 2008-2025
Basic
Statistic
Pfizer total assets 2006-2025
Premium
Statistic
Pfizer employees 2006-2025
Business distribution
4
Basic
Statistic
Pfizer revenue by global submarket 2010-2025
Premium
Statistic
Pfizer revenues in the U.S. and abroad 2009-2025
Premium
Statistic
Pfizer's revenue by segment 2022-2025
Premium
Statistic
Pfizer major products by revenue 2025
Competitors
5
Basic
Statistic
AbbVie revenue 2010-2025
Premium
Statistic
Merck & Co. revenue 2006-2025
Basic
Statistic
Sanofi revenue 2006-2025
Premium
Statistic
Johnson & Johnson revenue 2005-2025
Premium
Statistic
Roche Group's total sales 2006-2025
Research and development
5
Premium
Statistic
Total global pharmaceutical R&D spending 2016-2030
Premium
Statistic
Pfizer expenditure on research and development 2006-2025
Premium
Statistic
Top pharma companies worldwide 2026, by size of R&D pipeline
Basic
Statistic
Top pharma companies worldwide by number of originated drugs 2026
Premium
Statistic
BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
FURTHER REPORTS
Recommended and recent reports
Recommended statistics
You may also be interested in...